Deskripsi

Comparative analysis of antioxidant compounds evaluated for IBD treatment, illustrating differences in their molecular targets, bioavailability, or efficacy in reducing intestinal inflammation.

Figure 22

Diagram

Source Paper

Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel Disease.

Pharmaceuticals (Basel, Switzerland) (2023)

PMID: 37631065

DOI: 10.3390/ph16081150

Cite This Figure

![Figure 22: Comparative analysis of antioxidant compounds evaluated for IBD treatment, illustrating differences in their molecular targets, bioavailability, or efficacy in reducing intestinal inflammation.]()

> Source: Alexander V Blagov et al. "Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel D." *Pharmaceuticals (Basel, Switzerland)*, 2023. PMID: [37631065](https://pubmed.ncbi.nlm.nih.gov/37631065/)

<figure>
  <img src="" alt="Comparative analysis of antioxidant compounds evaluated for IBD treatment, illustrating differences in their molecular targets, bioavailability, or efficacy in reducing intestinal inflammation." />
  <figcaption>Figure 22. Comparative analysis of antioxidant compounds evaluated for IBD treatment, illustrating differences in their molecular targets, bioavailability, or efficacy in reducing intestinal inflammation.<br>  Source: Alexander V Blagov et al. "Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel D." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37631065/">37631065</a></figcaption>
</figure>

Bukti Terkait

Curcumin untuk Ulcerative Colitis (UC)

Peringkat B · 5 studi

N-Acetyl Cysteine (NAC) untuk Inflammatory Bowel Disease (IBD) — General

Peringkat D · 1 studi